データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
Conduit Pharmaceuticals Shares Are Trading Higher After the Company Announced That the Japan Patent Office Granted a Composition of Matter Patent for Its Lead Asset, AZD1656.
Press Release: Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors
10-Q:四半期報告書
10-Q/A:四半期報告書(訂正)
Conduit Pharmaceuticals Announces New Addition to Its Autoimmune Pipeline
データなし
データなし